| ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug‐resistant Gram‐negative bacteria in hospitalized patients E Tacconelli, MA Cataldo, SJ Dancer, G De Angelis, M Falcone, U Frank, ... Clinical Microbiology and Infection 20, 1-55, 2014 | 870 | 2014 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 839 | 2021 |
| Effect of tocilizumab vs standard care on clinical worsening in patients hospitalized with COVID-19 pneumonia: a randomized clinical trial C Salvarani, G Dolci, M Massari, DF Merlo, S Cavuto, L Savoldi, P Bruzzi, ... JAMA internal medicine 181 (1), 24-31, 2021 | 783 | 2021 |
| Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with E coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: a … PNA Harris, PA Tambyah, DC Lye, Y Mo, TH Lee, M Yilmaz, TH Alenazi, ... Jama 320 (10), 984-994, 2018 | 697 | 2018 |
| Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective … B Gutiérrez-Gutiérrez, E Salamanca, M de Cueto, PR Hsueh, P Viale, ... The Lancet Infectious Diseases 17 (7), 726-734, 2017 | 525 | 2017 |
| Cirrhotic patients are at risk for health care–associated bacterial infections M Merli, C Lucidi, V Giannelli, M Giusto, O Riggio, M Falcone, L Ridola, ... Clinical Gastroenterology and Hepatology 8 (11), 979-985. e1, 2010 | 383 | 2010 |
| Outcomes of patients hospitalized with community-acquired, health care–associated, and hospital-acquired pneumonia M Venditti, M Falcone, S Corrao, G Licata, P Serra, ... Annals of internal medicine 150 (1), 19-26, 2009 | 365 | 2009 |
| Ampicillin Plus Ceftriaxone Is as Effective as Ampicillin Plus Gentamicin for Treating Enterococcus faecalis Infective Endocarditis N Fernández-Hidalgo, B Almirante, J Gavaldà, M Gurgui, C Peña, ... Clinical infectious diseases 56 (9), 1261-1268, 2013 | 335 | 2013 |
| Whole-genome sequencing reveals host factors underlying critical COVID-19 A Kousathanas, E Pairo-Castineira, K Rawlik, A Stuckey, CA Odhams, ... Nature 607 (7917), 97-103, 2022 | 305 | 2022 |
| Efficacy of ceftazidime-avibactam plus aztreonam in patients with bloodstream infections caused by metallo-β-lactamase–producing Enterobacterales M Falcone, GL Daikos, G Tiseo, D Bassoulis, C Giordano, V Galfo, ... Clinical Infectious Diseases 72 (11), 1871-1878, 2021 | 305 | 2021 |
| Hypercoagulation and antithrombotic treatment in coronavirus 2019: a new challenge F Violi, D Pastori, R Cangemi, P Pignatelli, L Loffredo Thrombosis and haemostasis 120 (06), 949-956, 2020 | 290 | 2020 |
| Hyperglycemia at hospital admission is associated with severity of the prognosis in patients hospitalized for COVID-19: the Pisa COVID-19 study A Coppelli, R Giannarelli, M Aragona, G Penno, M Falcone, G Tiseo, ... Diabetes care 43 (10), 2345-2348, 2020 | 232 | 2020 |
| Cardiovascular complications and short-term mortality risk in community-acquired pneumonia F Violi, R Cangemi, M Falcone, G Taliani, F Pieralli, V Vannucchi, ... Clinical Infectious Diseases 64 (11), 1486-1493, 2017 | 224 | 2017 |
| JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality J Stebbing, G Sánchez Nievas, M Falcone, S Youhanna, P Richardson, ... Science advances 7 (1), eabe4724, 2021 | 207 | 2021 |
| Epidemiology, characteristics, and outcome of infective endocarditis in Italy: the Italian Study on Endocarditis S Leone, V Ravasio, E Durante-Mangoni, M Crapis, G Carosi, PG Scotton, ... Infection 40, 527-535, 2012 | 206 | 2012 |
| Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae M Falcone, M Bassetti, G Tiseo, C Giordano, E Nencini, A Russo, ... Critical Care 24, 1-12, 2020 | 196 | 2020 |
| Spotlight on ceftazidime/avibactam: a new option for MDR Gram-negative infections M Falcone, D Paterson Journal of Antimicrobial Chemotherapy 71 (10), 2713-2722, 2016 | 191 | 2016 |
| Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study E Estenssoro, CI Loudet, FG Ríos, VSK Edul, G Plotnikow, M Andrian, ... The Lancet Respiratory Medicine 9 (9), 989-998, 2021 | 183 | 2021 |
| Platelet activation is associated with myocardial infarction in patients with pneumonia R Cangemi, M Casciaro, E Rossi, C Calvieri, T Bucci, CM Calabrese, ... Journal of the American College of Cardiology 64 (18), 1917-1925, 2014 | 183 | 2014 |
| Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study M Tumbarello, F Raffaelli, M Giannella, E Mantengoli, A Mularoni, ... Clinical Infectious Diseases 73 (9), 1664-1676, 2021 | 174 | 2021 |
